Skip to main content
Scroll To Top
Home
Contact Us
Login
Create account
Search form
Search
About Us
Vision, Mission and Values
What We Do
Become a Member
Services
Board of Directors
Staff
Contact Us
Build Skills & Knowledge
Calendar of Events
PNY Core
Racial Equity
Leadership Development
Recorded Programs
Resources
Regional Calendar
Network
Networks & Working Groups
Committees & Advisory Groups
Member Directory
Public Policy
Why We Engage
Policy Priorities & Positions
Committee
News
Member News
Insights
Editorial Guidelines
Appointments and Transitions
PNY News
Jobs in Philanthropy
About Us
Vision, Mission and Values
What We Do
Become a Member
Membership Eligibility and Structure
Services
Conference Facilities
Consultant & Vendor Recommendations
Family Philanthropy Resources
Fiscal Sponsorship
Salary & Benefits Survey
Member Directory
Board of Directors
Committees & Advisory Groups
Past Board Chairs
Staff
Contact Us
Build Skills & Knowledge
Calendar of Events
PNY Core
Legal Series
Philanthropy 101
ESS
Financial Series
Evaluation Series
Policy Series
Racial Equity
Leadership Development
Recorded Programs
Resources
Regional Calendar
Network
Networks & Working Groups
Committees & Advisory Groups
Member Directory
Public Policy
Why We Engage
Policy Priorities & Positions
Committee
News
Member News
Insights
Editorial Guidelines
Appointments and Transitions
PNY News
Jobs in Philanthropy
Home
Contact Us
Login
Create account
You are here
Home
»
News
»
The Maker of OxyContin Tried to Make It Harder to Misuse. It May Have Led to More Heroin Deaths.
The Maker of OxyContin Tried to Make It Harder to Misuse. It May Have Led to More Heroin Deaths.
Monday, April 16, 2018
Read more @ Vox
Find More By
News type
Sector News
Funding Area
Health
